LAVAL, Quebec , July 27, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter financial results on Tuesday, Aug. 9, 2022. Bausch Health w
RBC Capital markets initiated coverage on Bausch + Lomb Corp (NYSE: BLCO) with an Outperform rating and a $22 price target.  The analysts see B+L as a diversified ophthalmology company with stro

Expert Ratings for Bausch Health Companies

05:24pm, Tuesday, 26'th Jul 2022 Benzinga
Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter:   Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 4 0 0 0
At least one group is bullish about the outlook for the medtech industry: venture capitalists.
Joseph Papa resigned chairman position. Solta IPO cancellation discussed.

Why Bausch Health Stock Is Bolting Higher Today

05:37pm, Friday, 24'th Jun 2022 The Motley Fool
An abrupt shake-up in the board of directors has investors piling into this healthcare stock today.
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider. ToughBu

Three-stock lunch: BA, WFC & BHC

03:34pm, Friday, 24'th Jun 2022
Lee Munson, Portfolio Wealth Advisors president and CIO, joins ‘Power Lunch' to weigh in on three stocks: Boeing, Wells Fargo and Bausch Health.
An abrupt shake-up in the board of directors has investors piling into this healthcare stock today.
The shares of Bausch Health Companies Inc (NYSE:BHC) are up 4.5% to trade at $7.55 ahead of the open, following changes to its board of directors.
Bausch Health Companies Inc. BHC, +2.97% disclosed Friday that Joseph Papa has resigned from the board of directors as of June 23. The specialty pharmaceutical company named John Paulson as its chairp
In January earlier this year, I wrote an article on Bausch Health Companies ( BHC , Financial), in which I speculated that the upcoming spin-off of the Bausch + Lomb eye care business and its aestheti

Bausch (BHC) Suspends IPO Plans for Solta Medical

01:36pm, Friday, 17'th Jun 2022 Zacks Investment Research
Bausch (BHC) suspends its plans for the initial public offering of its Solta Medical business in light of the challenging market conditions and other factors.
Bausch Health Cos. Inc. halts plans to proceed with the initial public offering of its skin-care business, citing "challenging market conditions."
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE